Amphion Innovations
10
4M
5
0.27
3
0.50
3
- Stages of investment
- Areas of investment
Summary
Amphion Innovations appeared to be the VC, which was created in 1984. The company was established in North America in United States. The leading representative office of defined VC is situated in the New York.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Amphion Innovations, startups are often financed by Danisco Venture. In the next rounds fund is usually obtained by Nokia, HSBC Bank, EASME - EU Executive Agency for SMEs.
Comparing to the other companies, this Amphion Innovations performs on 1 percentage points more the average number of lead investments. The fund is generally included in less than 2 deals every year. The increased amount of exits for fund were in 2015. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2006. The common things for fund are deals in the range of 1 - 5 millions dollars.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Software, Medical. Among the various public portfolio startups of the fund, we may underline Kromek, Motif BioSciences, FireStar Software Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 3
- Exits
- 3
- Rounds per year
- 0.27
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (7)
- Information Technology (5)
- Genetics (5)
- Health Care (4)
- Dietary Supplements (3) Show 9 more
- Investments by region
-
- United States (8)
- United Kingdom (2)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Group Appearance index
- 0.10
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Motif BioSciences | 05 Apr 2007 | Biotechnology, Health Care, Genetics | Late Stage Venture | 1M | United States, New York, New York |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.